Treating Alcohol Use In Older Adults With Depression

Sponsor
US Department of Veterans Affairs (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT00018824
Collaborator
(none)
74
1
2
63
1.2

Study Details

Study Description

Brief Summary

The purpose of this study is to test the efficacy combining a treatment for depression with a treatment for alcohol dependence.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

This study aims to study 80 patients with comorbid alcohol dependence and a depressive syndrome. After appropriate detoxification, patients are started on either naltrexone 50 mg or placebo. After one week, sertraline is added in an open label fashion. It is hypothesized that those patients receiving combination therapy will last 3 months with follow-up tracking lasting 1 year.

Study Design

Study Type:
Interventional
Actual Enrollment :
74 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Treatment of Late Life Major Depression Complication by Alcohol
Study Start Date :
Oct 1, 1999
Actual Primary Completion Date :
Jan 1, 2005
Actual Study Completion Date :
Jan 1, 2005

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Naltrexone

Drug: NALTREXONE

Placebo Comparator: 2

Placebo

Drug: Placebo

Outcome Measures

Primary Outcome Measures

  1. Alcohol use' [12 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
55 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age > 55

  • Current depressive syndrome

  • Current alcohol dependence

  • No psychosis

  • No opioid or cocaine abuse or dependence

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Pennsylvania Philadelphia Pennsylvania United States 19104

Sponsors and Collaborators

  • US Department of Veterans Affairs

Investigators

  • Principal Investigator: David W. Oslin, MD, University of Pennsylvania

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00018824
Other Study ID Numbers:
  • MHBS-009-98S
First Posted:
Jul 5, 2001
Last Update Posted:
Sep 23, 2009
Last Verified:
Sep 1, 2009
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 23, 2009